Abbott initiates ground-breaking U.S. pivotal study of AMPLATZER device to correct common congenital heart defect in newborns

- 80,000 PRE-TERM BABIES IN THE U.S. ARE BORN WITH A LIFE-THREATENING OPENING IN THEIR HEART EACH YEAR, AND 16,000 OF THEM NEED URGENT TREATMENT TO SURVIVE
Source: Abbott.com - Category: Pharmaceuticals Source Type: news